| April 2009, the new official launch of a comprehensive health care reform, pharmaceutical industry will also be long-term benefit from the advancement of medical reform, the industry also welcomed the development of new starting point. Changing the face of fluctuating pattern of the pharmaceutical market, Harbin Pharmaceutical Group Pharmaceutical Factory, Ltd. three fine as the province's largest manufacturer of solid dosage forms, the face of the opportunities and challenges. This thesis research marketing strategy, with three fine Pharmaceutical Factory, Ltd. as the background status of pharmaceutical marketing, marketing environment by analyzing the opportunities and threats, from the inspection company owned by its strengths, weaknesses departure, based on the corporate status quo in the rational understanding of the level of research and analysis business marketing mix issues, and draw the appropriate conclusions.Paper first introduces the three fine Harbin Pharmaceutical Group Co., Ltd. Pharmaceutical Factory, a marketing situation analysis of existing enterprise marketing portfolio irrational pricing due to science, and marketing issues such as poor access to and from the company's objective subjective factors leading enterprise capabilities and personnel aspects of the overall quality of the causes. Second, from the macro environment, consumer demand, raw material supply and alternatives analyzed in terms of three fine Harbin Pharmaceutical Group Co., Ltd. Pharmaceutical Factory, the market environment and demand from consumers, products, and other aspects of regional market segmentation and selection enterprises to adapt to the target market and product market positioning. Again from the product mix, pricing, channel, promotion and so constructed four factories in three intensive marketing strategies. That the final product from the marketing mix, price, place, promotion and other aspects of a series of measures consistent with the development of enterprises. |
PDF Full Text Request